Indian markets see renewed investor interest in pharma, speciality chemicals, and exchange-traded services, with recent earnings showing mixed signals. Pharma valuations are attractive, with Sun Pharma and MNCs like GSK and Pfizer showing promise. Speciality chemicals require patience, while BSE’s performance is linked to market sentiment and NSE’s upcoming listing.
Gold and silver rally set to continue as dollar weakness looms: Peter Schiff
Renowned investor Peter Schiff predicts continued gains for gold and silver, driven by a weakening U.S. dollar and shifting global monetary trends. He cites a